Practice
Featured experience
Cellular Biomedicine Group CAR-T collaboration and license agreement with Janssen
We are advising Cellular Biomedicine Group on the transaction
NBCUniversal partnership with MultiChoice to relaunch Showmax using Peacock
We are advising NBCUniversal on the transaction to relaunch MultiChoice’s Showmax service using the Peacock platform
Taboola and Yahoo enter 30-year commercial agreement
We advised Taboola on the transaction
Comcast streaming platform JV with Charter
We are advising Comcast on the transaction
LKQ $1.4 billion senior notes offering
The senior notes are due 2028 and 2033
Veeco Instruments $230 million convertible senior notes offering
The 2.875% convertible senior notes are due 2029
Emergent BioSolutions $150 million at-the-market offering
The shares are listed on the NYSE
Forbion European Acquisition combination with enGene
We are advising Forbion European Acquisition on its de-SPAC transaction
Bloom Energy $632.5 million green convertible notes and capped call transactions
The 3% green convertible senior notes are due 2028
Mirion Technologies $52.9 million secondary offering
The shares are listed on the NYSE
Schlumberger $1 billion senior notes offering
The investment-grade notes are due 2028 and 2033
Black Spade Acquisition $23 billion combination with VinFast
We are advising Black Spade on its de-SPAC transaction
GSK exclusive licensing agreement with Scynexis
We advised GSK on the transaction
Olema Pharmaceuticals $100 million at-the-market offering
The shares are listed on the Nasdaq Global Select Market